Estring
Payments companies reported to CMS as associated with Estring. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Estring, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Estring
These are the largest totals companies reported as associated with Estring. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Goldstein | New York, NY | Obstetrics & Gynecology | $127,206.93 |
| John Curtin | Denver, CO | Gynecologic Oncology | $16,585.00 |
| Lev Kandinov | Aventura, FL | Obstetrics & Gynecology | $284.55 |
| Dawn Broderick | Olney, MD | Internal Medicine | $172.07 |
| Gloria Laverde | Hallandale Beach, FL | Family | $160.57 |
| Emma Cotton | Brockton, MA | Medical | $159.58 |
| Graciela Roque Linares | Miami, FL | Family | $151.79 |
| Cherry Lobaton | Martinsburg, WV | Family Medicine | $143.11 |
| Miriam Greene | New York, NY | Obstetrics & Gynecology | $138.02 |
| Carlos Vizcarra | Sebastian, FL | Internal Medicine | $136.95 |
Prescribed Estring?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.